CAS 101901-08-0: ethyl [8-(1-hydroxyethyl)-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate

1'-Hydroxy etodolac is an inhibitor of kinases, which are enzymes that play a key role in cellular signaling pathways. It has been shown to inhibit the activity of oseltamivir carboxylate, a metabolite of the antiviral drug oseltamivir, in human urine. Additionally, 1'-Hydroxy etodolac has been found to induce apoptosis (programmed cell death) in cancer cells through its effects on protein kinase inhibitors. This analog has demonstrated potent anticancer activity against various types of tumors, including Chinese hamster lung cells and human breast cancer cells. Its potential as a therapeutic agent for cancer treatment is currently being explored.